IMVT Chart
See on advanced chart >
About
Immunovant, Inc.was incorporated in Delaware on December 6, 2018.The company is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.
Read More
- HighlightA clinical-stage biopharmaceutical company that developing therapies for autoimmune diseases
- ExchangeNASDAQ
- Listing Date06/21/2019
- Established Date12/06/2018
- Full-time Employees207
- Address320 West 37th Street New York NY 10018
- Tel1-917-5803099
- Website
- Fiscal Year End Date03/31
- Security TypeCommon Stock
Industry
Pharmaceuticals